{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:24:48Z","timestamp":1793118288458,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.modpat.2026.101007","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:24:12Z","timestamp":1777559052000},"page":"101007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["NTRK Fusion Landscape in 195 Positive Cases of 17 Tumors: A Chinese Multicenter Retrospective Study With Optimized Pan-TRK Immunohistochemistry (IHC) Screening"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2570-6280","authenticated-orcid":false,"given":"Shafei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingchuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaimi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-2925","authenticated-orcid":false,"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 8","key":"10.1016\/j.modpat.2026.101007_bib1","doi-asserted-by":"crossref","first-page":"viii16","DOI":"10.1093\/annonc\/mdz384","article-title":"Identifying patients with NTRK fusion cancer","volume":"30","author":"Solomon","year":"2019","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00183","article-title":"Analysis of NTRK alterations in pan-cancer adult and pediatric malignancies: implications for NTRK-targeted therapeutics","volume":"2","author":"Okamura","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"21","key":"10.1016\/j.modpat.2026.101007_bib4","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1111\/1759-7714.14644","article-title":"Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China","volume":"13","author":"Xu","year":"2022","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.modpat.2026.101007_bib5","article-title":"NTRK fusions identified in pediatric tumors: the frequency, fusion partners, and clinical outcome","volume":"1","author":"Zhao","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101007_bib6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1078-0432.CCR-19-3165","article-title":"TRK fusions are enriched in cancers with uncommon histologies and the absence of canonical driver mutations","volume":"26","author":"Rosen","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.modpat.2026.101007_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"issue":"13","key":"10.1016\/j.modpat.2026.101007_bib9","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-19-0372","article-title":"Detection of NTRK fusions: merits and limitations of current diagnostic platforms","volume":"79","author":"Solomon","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2026.101007_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cancergen.2021.12.010","article-title":"Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing","volume":"262-263","author":"Koehne de Gonz\u00e1lez","year":"2022","journal-title":"Cancer Genet"},{"issue":"7","key":"10.1016\/j.modpat.2026.101007_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101007_bib12","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s12094-021-02558-0","article-title":"Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours","volume":"23","author":"Garrido","year":"2021","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101007_bib13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/diagnostics12030668","article-title":"Detection of NTRK fusions and TRK expression and performance of pan-TRK immunohistochemistry in routine diagnostics: results from a nationwide community-based cohort","volume":"12","author":"Koopman","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-023-01426-5","article-title":"Validation and interpretation of pan-TRK immunohistochemistry: a practical approach and challenges with interpretation","volume":"19","author":"Karakas","year":"2024","journal-title":"Diagn Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101007_bib15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41379-020-00657-x","article-title":"Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions","volume":"34","author":"Br\u010di\u0107","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib16","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1038\/s41598-023-31055-3","article-title":"Systematic review of NTRK 1\/2\/3 fusion prevalence pan-cancer and across solid tumours","volume":"13","author":"O'Haire","year":"2023","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.modpat.2026.101007_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jcp-2023-208865","article-title":"NTRK gene alterations were enriched in hepatoid or enteroblastic differentiation type of gastric cancer","volume":"77","author":"Pu","year":"2024","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101007_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cjp2.324","article-title":"NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS","volume":"9","author":"Zito Marino","year":"2023","journal-title":"J Pathol Clin Res"},{"issue":"9","key":"10.1016\/j.modpat.2026.101007_bib19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchi\u00f2","year":"2019","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101007_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2026.101007_bib21","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1002\/cncr.32832","article-title":"Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)","volume":"126","author":"Xu","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2026.101007_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100192","article-title":"Multicenter harmonization study of pan-Trk immunohistochemistry for the detection of NTRK3 fusions","volume":"36","author":"Adam","year":"2023","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101007_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00428-020-02921-6","article-title":"Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial","volume":"478","author":"De Winne","year":"2021","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.modpat.2026.101007_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejca.2022.06.030","article-title":"The sensitivity of pan-TRK immunohistochemistry in solid tumours: a meta-analysis","volume":"173","author":"Hondelink","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.modpat.2026.101007_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cancergen.2022.01.004","article-title":"The promise of TRK inhibitors in pediatric cancers with NTRK fusions","volume":"262-263","author":"Blauel","year":"2022","journal-title":"Cancer Genet"},{"key":"10.1016\/j.modpat.2026.101007_bib26","article-title":"Establishing optimized staining protocol and cutoff values of pan-TRK immunohistochemistry for detecting NTRK fusions in solid tumors: a Chinese multicenter cross-sectional study","volume":"42","author":"Wu","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5603\/OCP.2023.0024","article-title":"Pan-TRK immunohistochemistry as a tool in the screening for NTRK gene fusions in cancer patients","volume":"20","author":"Durzy\u0144ska","year":"2024","journal-title":"Oncol Clin Pract"},{"issue":"3","key":"10.1016\/j.modpat.2026.101007_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.32074\/1591-951X-787","article-title":"NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies","volume":"114","author":"Marchetti","year":"2022","journal-title":"Pathologica"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-021-00206-y","article-title":"Genomic context of NTRK1\/2\/3 fusion-positive tumours from a large real-world population","volume":"5","author":"Westphalen","year":"2021","journal-title":"NPJ Precis Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101007_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jmoldx.2019.03.008","article-title":"Detection of tumor NTRK gene fusions to identify patients who may benefit from tyrosine kinase (TRK) inhibitor therapy","volume":"21","author":"Hsiao","year":"2019","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41698-023-00427-3","article-title":"Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in China","volume":"7","author":"Xu","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101007_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jmoldx.2023.04.007","article-title":"Molecular and cytogenetic features of NTRK fusions enriched in BRAF and RET double-negative papillary thyroid cancer","volume":"25","author":"Wu","year":"2023","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.modpat.2026.101007_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7351","article-title":"Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan","volume":"13","author":"Nakata","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12022-025-09852-5","article-title":"Refining NTRK fusion detection in papillary thyroid carcinoma through pan-TRK immunohistochemistry and histopathologic features","volume":"36","author":"Lee","year":"2025","journal-title":"Endocr Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101007_bib35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/his.14884","article-title":"A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types","volume":"82","author":"Haberecker","year":"2023","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2026.101007_bib36","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1038\/s41598-021-89373-3","article-title":"Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma","volume":"11","author":"Strohmeier","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.modpat.2026.101007_bib37","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s00432-021-03578-7","article-title":"Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma","volume":"147","author":"Yu","year":"2021","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:23:24Z","timestamp":1784114604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0893395226000505"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101007","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NTRK Fusion Landscape in 195 Positive Cases of 17 Tumors: A Chinese Multicenter Retrospective Study With Optimized Pan-TRK Immunohistochemistry (IHC) Screening","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101007"}}